ALLR Allarity Therapeutics, Inc.
Nasdaq · SEC CIK 1860657 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 17 since 2024-10-01, latest 2026-05-14 11:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Graff Jeremy R. | See Remarks | — | — |
| Jensen Thomas | CEO | — | — |
| Ervin Jeffrey S | CFO | — | — |
| Hoeiland Jesper | Dir | — | — |
| McLaughlin Gerald W. | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 11:48 | 2026-01-28 | ALLR | Jensen Thomas | CEO | A - Grant | $0.00 | +200.0K | 596.7K | +50% | $0 | |
| 2026-05-11 15:21 | 2026-01-07 | ALLR | Hoeiland Jesper | Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 | |
| 2026-05-07 18:25 | 2026-01-28 | ALLR | McLaughlin Gerald W. | Dir | A - Grant | $0.00 | +45.0K | 70.0K | +180% | $0 | |
| A | 2026-04-30 15:38 | 2026-01-28 | ALLR | Graff Jeremy R. | See Remarks | A - Grant | $0.00 | +133.3K | 381.6K | +54% | $0 |
| 2026-04-30 15:37 | 2026-01-28 | ALLR | Ervin Jeffrey S | CFO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 | |
| 2026-01-16 | 2026-01-07 | ALLR | Graff Jeremy R. | See Remarks | A - Grant | $0.00 | +133.3K | 381.6K | +54% | $0 | |
| D | 2025-10-02 | 2025-09-30 | ALLR | Graff Jeremy R. | See Remarks | M - OptEx | — | +39.5K | 39.5K | New | — |
| D | 2025-10-02 | 2025-09-30 | ALLR | Graff Jeremy R. | See Remarks | F - Tax | $1.58 | -14.6K | 24.9K | -37% | -$23.1K |
| 2025-01-24 | 2025-01-22 | ALLR | Jensen Thomas | CEO | A - Grant | $0.00 | +396.7K | 396.7K | New | $0 | |
| 2025-01-24 | 2025-01-22 | ALLR | Epshinsky Alexander | CFO | A - Grant | $0.00 | +29.5K | 85.1K | +53% | $0 | |
| 2025-01-24 | 2025-01-22 | ALLR | Graff Jeremy R. | CDO | A - Grant | $0.00 | +144.4K | 262.9K | +122% | $0 | |
| 2024-10-01 | 2024-09-30 | ALLR | Graff Jeremy R. | See Remarks | A - Grant | $2.11 | +118.5K | 118.5K | New | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations